Article | September 28, 2020

The Future Of Clinical Research Technology

Source: Complion
Crystal-ball-future

No human endeavor is immune to change, and that is certainly true for clinical research. John Neal, CEO of PCRS Network, spent a year talking to sponsors, management, and other various roles in clinical research in an effort to identify the factors that are shaping the future of clinical research. And while the views vary, one factor looms above all others.

“There’s a consensus that the system is broken,” says Neal. “It’s not sustainable. It all comes down to money.”

According to Neal’s research, the average cost to take a drug from discovery through approval is $1.5 billion. And the cost isn’t dropping.

“Every indication is that without change, that number’s going to continue to increase,” Neal adds. “That is especially true for larger pharmaceutical companies that are testing multiple drugs trying to bring multiple products to market. Some of those drugs don’t make it, which raises the average cost of the drugs that do make it to market. As an industry we need to change, and there are plenty of things that are going to drive that change.”

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: